I really hope we can cash in on the momentum of the ovarian...

I really hope we can cash in on the momentum of the ovarian cancer validation results due out this quarter with some intensive press releases if it turns out to be as close to 100% sensitivity and specificity that got the market so excited a couple of years ago . A real opportunity imo . Last time the moment was lost due to that VERY long silence …remember! We need to engage good young Science communicators who explain this type of stuff to the public all the time . There is always a need for good content apparently and we have a story to tell .